selected publications
- Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy. Crohn's & colitis 360. 2024 Academic Article GET IT
- Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review. Inflammatory bowel diseases. 2024 Academic Article GET IT
- Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: SAPPHIRE Registry. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2024 Academic Article GET IT
- Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2024 Academic Article GET IT
- The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis. Cell reports. Medicine. 2024 Academic Article GET IT
- An Unusual Hiccup: Severe Singultus as a Symptom in Ulcerative Colitis. 2024 GET IT
- Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease. Journal of clinical medicine. 2023 Academic Article GET IT
- The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease. Journal of clinical gastroenterology. 2023 Academic Article GET IT
- Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn's disease: the debate continues. Translational gastroenterology and hepatology. 2023 Review GET IT
- Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity. Journal of Crohn's & colitis. 2023 Editorial Article GET IT
-
PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease.
Digestive diseases and sciences.
2023
Editorial Article
GET IT
Times cited: 46 - The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease. Crohn's & colitis 360. 2023 Academic Article GET IT
- Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease. Inflammatory bowel diseases. 2022 Academic Article GET IT
- COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study. Therapeutic advances in gastroenterology. 2022 Academic Article GET IT
- Article Topic: Positioning Ulcerative Colitis Therapies in 2022 and Beyond. Current gastroenterology reports. 2022 Review GET IT
- Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease. Journal of Crohn's & colitis. 2022 Academic Article GET IT
- Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach. Journal of gastroenterology and hepatology. 2022 Academic Article GET IT
- The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results from the SUCCESS Consortium. The American journal of gastroenterology. 2022 Academic Article GET IT
- Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease. World journal of gastroenterology. 2022 Academic Article GET IT
-
A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.
Journal of clinical gastroenterology.
2022
Academic Article
GET IT
Times cited: 5 - Joint Disease Activity in Inflammatory Bowel Disease-associated Peripheral Spondyloarthritis Stratifies Therapeutic Response. Gastro hep advances. 2022 Academic Article GET IT
- Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease. Inflammatory bowel diseases. 2021 Academic Article GET IT
- No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2021 Article GET IT
- Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2021 Academic Article GET IT
- Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2021 Information Resource GET IT
-
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
Gastroenterology.
2021
Academic Article
GET IT
Times cited: 1 - Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics. Bioorganic chemistry. 2021 Academic Article GET IT
-
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2020
Academic Article
GET IT
Times cited: 37 - Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease. Crohn's & colitis 360. 2020 Academic Article GET IT
-
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
Alimentary pharmacology & therapeutics.
2020
Academic Article
GET IT
Times cited: 54 -
Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
Digestive diseases and sciences.
2020
Academic Article
GET IT
Times cited: 1 - Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease. 2020 GET IT
-
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
Gastroenterology.
2020
Academic Article
GET IT
Times cited: 89 -
Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.
Journal of gastroenterology.
2020
Information Resource
GET IT
Times cited: 7 -
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2020
Academic Article
GET IT
Times cited: 61 -
Incident heart failure is a predictor of adverse outcomes in inflammatory bowel disease.
European journal of gastroenterology & hepatology.
2020
Academic Article
GET IT
Times cited: 1 - Vaccination in the Elderly and IBD. Current treatment options in gastroenterology. 2019 Information Resource GET IT
-
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.
Inflammatory bowel diseases.
2019
Academic Article
GET IT
Times cited: 12 -
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Inflammatory bowel diseases.
2019
Academic Article
GET IT
Times cited: 8 -
Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.
Alimentary pharmacology & therapeutics.
2019
Academic Article
GET IT
Times cited: 5 -
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2019
Academic Article
GET IT
Times cited: 53 -
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
Inflammatory bowel diseases.
2018
Academic Article
GET IT
Times cited: 57 -
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2018
Academic Article
GET IT
Times cited: 68 -
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
The American journal of gastroenterology.
2018
Academic Article
GET IT
Times cited: 139 -
Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
2018
Academic Article
GET IT
Times cited: 6 -
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology.
2018
Academic Article
GET IT
Times cited: 109 -
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.
The American journal of gastroenterology.
2016
Academic Article
GET IT
Times cited: 176 - Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity. Nuclear receptor research. 2016 Academic Article GET IT
-
Microbial control of intestinal innate immunity.
Oncotarget.
2015
Editorial Article
GET IT
Times cited: 9 -
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2015
Academic Article
GET IT
Times cited: 52 -
p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints.
Molecular cancer research : MCR.
2014
Academic Article
GET IT
Times cited: 66 -
Long-lived intestinal tuft cells serve as colon cancer-initiating cells.
The Journal of clinical investigation.
2014
Academic Article
GET IT
Times cited: 312 -
Effect of comorbid conditions on adherence to colorectal cancer screening.
Journal of cancer education : the official journal of the American Association for Cancer Education.
2012
Academic Article
GET IT
Times cited: 20 -
p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.
The Journal of biological chemistry.
2012
Academic Article
GET IT
Times cited: 32 -
Posttranslational processing and differential glycosylation of Tractin, an Ig-superfamily member involved in regulation of axonal outgrowth.
Biochimica et biophysica acta.
2000
Academic Article
GET IT
Times cited: 9 -
Glutathione synthesis is essential for mouse development but not for cell growth in culture.
Proceedings of the National Academy of Sciences of the United States of America.
2000
Academic Article
GET IT
Times cited: 257